The Chlorhydroxyquinoline,benzoyl Pe, cataloged under National Stock Number 6505-00-230-2709, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Dermik Laboratories Inc Div of Rorer Group Inc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-230-2709 |
| Primary Part Number | NDC00066-0024-25 |
| Item Name | Chlorhydroxyquinoline,benzoyl Pe |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Dermik Laboratories Inc Div of Rorer Group Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 25.000 GRAMS G |
| Active Ingredient and Strength | 5.000 BENZOYL PEROXIDE PERCENTAGE, W/W AND 0.250 CHLORHYDROXYQUINOLIN PERCENTAGE, W/W AND 0.500 HYDROCORTISONE PERCENTAGE, W/W |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00066-0024-25 PRIMARY | Dermik Laboratories Inc Div of Rorer Group Inc (USA) |
| Reference | Meaning |
|---|---|
| VAN0XIDEHC | 3/9 Design control — primary reference Dermik Laboratories Inc Sub of Rorer Pharmaceutical Corp |
NSN 6505-00-230-2709 is a Chlorhydroxyquinoline,benzoyl Pe, manufactured by Dermik Laboratories Inc Div of Rorer Group Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-230-2709 has 1 manufacturer part number on file: NDC00066-0024-25 (Dermik Laboratories Inc Div of Rorer Group Inc).
Key specifications for NDC00066-0024-25: Primary Container Content Quantity: 25.000 GRAMS G; Active Ingredient and Strength: 5.000 BENZOYL PEROXIDE PERCENTAGE, W/W AND 0.250 CHLORHYDROXYQUINOLIN PERCENTAGE, W/W AND 0.500 HYDROCORTISONE PERCENTAGE, W/W; Primary Container Type: BOTTLE; Special Features: PHARMACEUTICAL VEHICLE TYPE:AQUEOUS;ADMINISTRATION:TOPICAL. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.